ConductScience.org, home

Paper26323422

Mucoadhesive Chitosan Derivatives as Novel Drug Carriers.

Islam MA and 10 others. Curr Pharm Des, 2015. Cited by 43 papers, by iCite.

Cite this record

ConductScience Library. Mucoadhesive Chitosan Derivatives as Novel Drug Carriers. Papers, record 26323422. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/26323422

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Mucoadhesive Chitosan Derivatives as Novel Drug Carriers.
PubMed
Journal
Curr Pharm Des
PubMed
Year
2015
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
43
iCite
Relative citation ratio, by iCite
2.02
iCite
Revised in PubMed
2019-07-28
PubMed

Authors11

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Islam MAMohammad Ariful
2Park TETae-Eun
3Reesor EEmma
4Cherukula KKondareddy
5Hasan AAnwarul
6Firdous JJannatul
7Singh BBijay
8Kang SKSang-Kee
9Choi YJYun-Jaie
10Park IKIn-Kyu
11Cho CSChong-Su

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ChitosanMajor topic
Drug CarriersMajor topic
Mucous MembraneMajor topic
Adhesiveness
Animals
Drug Delivery Systems
Humans
Mucins
Nanostructures

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.

PMIDTitleJournalYearIn PapersSource
40337306From genetic code to global health: the impact of nucleic acid vaccines on disease prevention and treatment.RSC Med Chem2025https://conductscience.org/library/papers/40337306PubMed
38887635Chitosan alchemy: transforming tissue engineering and wound healing.RSC Adv2024https://conductscience.org/library/papers/38887635PubMed
38475368Intranasal Ion-Triggered In Situ Delivery System of Virus-like Particles: Development Using the Quality by Design Approach.Polymers (Basel)2024https://conductscience.org/library/papers/38475368PubMed
37964169Chitosan nanoparticles encapsulating farnesol evaluated in vivo against Candida albicans.Braz J Microbiol2024https://conductscience.org/library/papers/37964169PubMed
37896217Nanoparticle-Mediated Strategies for Enhanced Drug Penetration and Retention in the Airway Mucosa.Pharmaceutics2023https://conductscience.org/library/papers/37896217PubMed
37177171Optimization of a Mucoadhesive Vaginal Gel Containing Clotrimazole Using a D-Optimal Experimental Design and Multivariate Analysis.Polymers (Basel)2023https://conductscience.org/library/papers/37177171PubMed
37102920Gel Formulations with an Echinocandin for Cutaneous Candidiasis: The Influence of Azone and Transcutol on Biopharmaceutical Features.Gels2023https://conductscience.org/library/papers/37102920PubMed
36678762Synthesis and Characterization of Innovative Microgels Based on Polyacrylic Acid and Microalgae Cell Wall and Their Potential as Antigen Delivery Vehicles.Pharmaceutics2022https://conductscience.org/library/papers/36678762PubMed
36616453The Use of Polymers to Enhance Post-Orthodontic Tooth Stability.Polymers (Basel)2022https://conductscience.org/library/papers/36616453PubMed
36593953Recent advances in the medical applications of hemostatic materials.Theranostics2023https://conductscience.org/library/papers/36593953PubMed
36466349The application of nanotechnology in treatment of Alzheimer's disease.Front Bioeng Biotechnol2022https://conductscience.org/library/papers/36466349PubMed
35875806Nanomedicines in the Management of Alzheimer's Disease: Current View and Future Prospects.Front Aging Neurosci2022https://conductscience.org/library/papers/35875806PubMed
35056788Chitosan Nanoparticle-Based System: A New Insight into the Promising Controlled Release System for Lung Cancer Treatment.Molecules2022https://conductscience.org/library/papers/35056788PubMed
34992363Protective Effects of Chitosan-Bilirubin Nanoparticles Against Ethanol-Induced Gastric Ulcers.Int J Nanomedicine2021https://conductscience.org/library/papers/34992363PubMed
34940319New Formulations Loading Caspofungin for Topical Therapy of Vulvovaginal Candidiasis.Gels2021https://conductscience.org/library/papers/34940319PubMed
34926557A Review on Polymer and Lipid-Based Nanocarriers and Its Application to Nano-Pharmaceutical and Food-Based Systems.Front Nutr2021https://conductscience.org/library/papers/34926557PubMed
34771955Fluorescent Chitosan Modified with Heterocyclic Aromatic Dyes.Materials (Basel)2021https://conductscience.org/library/papers/34771955PubMed
34304387Mucosal Vaccine Delivery Using Mucoadhesive Polymer Particulate Systems.Tissue Eng Regen Med2021https://conductscience.org/library/papers/34304387PubMed
34203816Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption.Pharmaceutics2021https://conductscience.org/library/papers/34203816PubMed
33925332A Review on Current Trends of Polymers in Orthodontics: BPA-Free and Smart Materials.Polymers (Basel)2021https://conductscience.org/library/papers/33925332PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/26323422

GET https://conductscience.org/api/papers/v1/26323422/cited_by?page=2